The Value Chain Shift: From IP Commercialization to Legacy Capital
Global Report·- The Hong Kong stock market is undergoing a structural divergence driven by core intellectual property, global supply chains, and platform effects. - Companies like Everest Medicines and Weichai Power achieved robust financial growth in 2026 by successfully commercializing products and expanding global networks. - Capital and traditional sectors are actively rebalancing their portfolios toward technology innovation while navigating ongoing asset cycles.Tongrentang Healthcare falls 6% after IPO stabilisation period ends
HK Stock Market Update·Tongrentang Medical (2667.HK) climbs 3% in Hong Kong trading
HK Stock Market Update·